Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
The classification and definition of the hypertensive disorders of pregnancy
1988 • 1,329 citations
FETAL OUTCOME IN TRIAL OF ANTIHYPERTENSIVE TREATMENT IN PREGNANCY
1976 • 289 citations
PLACEBO-CONTROLLED TRIAL OF ATENOLOL IN TREATMENT OF PREGNANCY-ASSOCIATED HYPERTENSION
1983 • 213 citations
Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
1979 • 158 citations
A CONTROLLED TRIAL OF HYPOTENSIVE AGENTS IN HYPERTENSION IN PREGNANCY
1968 • 127 citations
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
1983 • 120 citations
HYPERTENSION DURING PREGNANCY WITH AND WITHOUT SPECIFIC TREATMENT; THE DEVELOPMENT OF THE CHILDREN AT THE AGE OF FOUR YEARS
1980 • 99 citations
Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre‐eclampsia
1986 • 84 citations
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
1985 • 80 citations
Comparison of the Alpha and Beta Blocking Drug, Labetalol, and Methyl Dopa in the Treatment of Moderate and Severe Pregnancy-Induced Hypertension
1980 • 73 citations
The effect of maternal labetalol on the newborn infant
1986 • 62 citations
Neonatal effects of maternal administration of acebutolol.
1981 • 44 citations
Pharmacology of Combined ??-??-Blockade I
1984 • 39 citations
Fetal and Neonatal Effects of the Beta-Adrenoceptor Blocking Agents
1987 • 36 citations
Cited By (0)
No citing papers found in database